Zero Gravity

Zero Gravity Therapeutics is a private biotech startup developing hydrogel-based drug delivery technologies for chronic inflammation and immune dysregulation. The company is using simulated microgravity and planned space-based manufacturing workflows to engineer multiscale hydrogel architectures designed for precise, sustained local delivery while reducing systemic side effects. Its core platform, Fractagels, is being developed as a biocompatible therapeutic hydrogel system with tunable structural properties. The company appears to be at an early research and preclinical stage, with its work centered more on platform creation than on a disclosed traditional clinical pipeline. Zero Gravity Therapeutics positions itself within space medicine and advanced biomaterials, aiming to translate microgravity-enabled materials science into therapeutic applications on Earth.